Welcome to our dedicated page for Ndt Pharmaceuticals news (Ticker: NDTP), a resource for investors and traders seeking the latest updates and insights on Ndt Pharmaceuticals stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Ndt Pharmaceuticals's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Ndt Pharmaceuticals's position in the market.
NDT Pharmaceuticals (OTC:NDTP) announced that its subsidiary Good Salt Life secured a contract with the Tennessee Department of Correction on November 24, 2025 to deploy Good Salt Life's biosafety ecosystem across state prisons.
The award includes $300,000 in initial ByoCart Sprayer unit purchases and is expected to generate recurring annual revenue from ongoing Clean Republic disinfectant replenishment, establishing a multi-year revenue stream and expanding NDTP's government institutional footprint.
NDT Pharmaceuticals (OTC PINK: NDTP) announced a post-acquisition commercial milestone after acquiring Good Salt Life on September 5, 2025. Good Salt Life received an expanded order from Norwegian Cruise Line for 20 induction-charged disinfectant sprayers that deploy EPA-approved hypochlorous acid (HOCl) solutions fleetwide for communal areas and staterooms.
The release highlights Good Salt Life's vertically integrated biosafety ecosystem (hardware, EPA-approved chemistries, data protocols), claims hospital-grade disinfection using an electrolysis process, and positions NDT to address the $148 billion global biosafety market across hospitality, healthcare, and transportation.
NDT Pharmaceuticals (OTC PINK: NDTP) announced that its subsidiary Good Salt Life has deployed the ByoCart Disinfection System at Baptist Hospital, the flagship facility of Baptist Health, on October 13, 2025.
The ByoCart system uses induction-charged air-scrubbing technology combined with automated surface disinfection to deliver dual-action protection: consistent surface coverage plus airborne contaminant capture to improve indoor air quality. The release highlights benefits including precision coverage of hard-to-reach surfaces, faster room turnover, automated dosing for reliability, and compatibility with existing EPA-approved disinfectant formulations.
Good Salt Life (OTC:NDTP) submitted a "me-too" registration to the U.S. EPA for its hypochlorous acid (HOCl) disinfectant seeking an efficacy claim for Clostridioides difficile (C. diff). If approved, the label expansion would allow marketing to hospitals and healthcare facilities concerned with C. diff infection control. The company cited the U.S. healthcare market exceeding $4 trillion and described partnerships on induction charged spray and air scrubbing technologies to enhance surface and air disinfection. Recent EPA registrations include Dog Gone Odor and PurrGuard. The company is awaiting the EPA decision.
NDT Pharmaceuticals (OTCID:NDTP) announced its subsidiary Good Salt™ Life's strategic expansion into the $148 billion global biosafety market with an innovative antimicrobial platform. The company's technology transforms salt and water into hypochlorous acid (HOCl) solutions through proprietary electrolysis, targeting home care, pet wellness, skincare, and professional biosafety sectors.
Good Salt Life has secured partnerships with major industry leaders including Virgin, Royal Caribbean, Carnival Corp, Cleveland Clinic, New York Yankees, and major retailers like Amazon, Walmart, and Chewy. The company's EPA-registered solutions are being implemented across various sectors including animal health, cruise industry, healthcare, government facilities, and sports venues.
The company is also investing in next-generation technologies including robotics, AI automation, and indoor air quality sensors to build a comprehensive safety solutions ecosystem.
NDT Pharmaceuticals (OTC:NDTP) has completed the acquisition of Good Salt Life, LLC, an Athens, Georgia-based biosafety and infection control innovator, on September 5, 2025. Good Salt Life specializes in infection control ecosystems with proprietary hardware and EPA-approved chemistries, operating across 11 countries and 8 industries.
The acquired company serves major clients including Merck Animal Health, United Airlines, Carnival Cruise Line, Marriott, and the NFL. Good Salt Life's portfolio encompasses consumer pet care, home care, cosmetics, antimicrobial chemistry, and chemical delivery technology. The integration aims to create cleaner, safer, and healthier solutions while focusing on sustainability and innovation.
FAQ
What is the current stock price of Ndt Pharmaceuticals (NDTP)?
What is the market cap of Ndt Pharmaceuticals (NDTP)?
